Screening for diabetic retinopathyBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7047.1670 (Published 29 June 1996) Cite this as: BMJ 1996;312:1670
Diabetic patients should continue to be assessed by direct ophthalmoscopy
- P M Hart,
- D B Archer,
- A B Atkinson
- Consultant community ophthalmologist Professor Department of Ophthalmology, Royal Victoria Hospital, Belfast BT12 6BA
- Consultant physician Sir George E Clark Metabolic Unit, Royal Victoria Hospital, Belfast BT12 6BA
EDITOR,—There has been much discussion in the BMJ recently about the merits and shortcomings of various modes of screening for diabetic retinopathy.1 2 3 Many diabetologists and general practitioners are now confused about the value of regular direct ophthalmoscopy for their diabetic patients because of its perceived poor sensitivity.
This is of great concern, and we think that a clearer distinction must be made between screening for any retinopathy and screening for sight threatening retinopathy (that is, proliferative retinopathy or macular oedema). …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial